论文部分内容阅读
目的:观察2型糖尿微量白蛋白采用黄芪注射液治疗的效果。方法:选取2013年1月-2014年,我院收治的173例2型糖尿病患者,随机分成两组。比对组的86例患者,给予常规500ml/天,静脉滴注,2周为一个疗程;观察组的87例患者在常规治疗的基础上,在250ml、0.9%氯化钠注射液中加入20ml黄芪注射液,1次/天,静脉滴注,2周为一个疗程。对两组患者的治疗前后,空腹静脉血浆葡萄糖(FPG)、尿微量白蛋白(UAE)连续2天的24小时平均值、休息状态的下卧位右侧肱动脉压。结果:比对组的86例糖尿病患者,糖尿微量白蛋白在治疗前后没有明显变化;观察组的87例糖尿病患者,在治疗前后,尿微量白蛋白下降明显,组内比较差异显著,且P<0.05,具有统计学意义;两组之间比较,观察组具有明显优势,且P<0.05,差异具有统计学意义。结论:对2型糖尿病患者采用黄芪注射液治疗,能够有效降低患者尿微量白蛋白,提高治愈率,值得在临床中推广应用。
Objective: To observe the effect of type 2 diabetes microalbumin treated with astragalus injection. Methods: 173 patients with type 2 diabetes treated in our hospital from January 2013 to 2014 were randomly divided into two groups. Eighty-six patients in the comparison group were given conventional 500ml / day intravenous drip for 2 weeks. 87 patients in the observation group were given 20ml of 250ml 0.9% sodium chloride injection on the basis of routine treatment Astragalus injection, 1 / day, intravenous infusion, 2 weeks for a course of treatment. Fasting venous plasma glucose (FPG) and urinary microalbuminuria (UAE) were measured for 24-hour mean of 2 consecutive days before and after treatment, and right brachial artery pressure at rest in both groups before and after treatment. Results: There were no significant changes in urinary albumin before and after treatment in 86 patients with diabetes mellitus in the comparison group. Urinary microalbumin decreased significantly in 87 patients with diabetes mellitus before and after treatment in the observation group, with significant difference (P < 0.05, with statistical significance; between the two groups, the observation group has obvious advantages, and P <0.05, the difference was statistically significant. Conclusion: The treatment of astragalus with type 2 diabetes mellitus patients can effectively reduce the urine microalbuminuria and improve the cure rate, which is worth popularizing in the clinic.